Chu Xinyun, Pu Ning, Yang Xue, Xie Yuqi, Liu Liang, Jin Yun
Department of Hepatobiliary & Pancreatic Surgery, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan 650000, China; Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Crit Rev Oncol Hematol. 2025 Aug;212:104763. doi: 10.1016/j.critrevonc.2025.104763. Epub 2025 May 5.
Neutrophils are essential components of the innate immune system. Tumor-associated neutrophils (TANs) are shaped by tumor microenvironment (TME), leading to significant heterogeneity in biological characteristics and functions. Recent advances in single-cell sequencing have revealed a wide array of TAN subtypes, while a comprehensive classification system is still lacking. This review aims to summarize the alterations observed in TAN subgroups following cancer immunotherapy, and identify the distinctions and commonalities between pro-tumor and anti-tumor subgroups. Current progress of preclinical and clinical studies is also highlighted, involving novel therapies targeting TANs.
中性粒细胞是固有免疫系统的重要组成部分。肿瘤相关中性粒细胞(TANs)由肿瘤微环境(TME)塑造,导致其生物学特性和功能存在显著异质性。单细胞测序的最新进展揭示了多种TAN亚型,但仍缺乏全面的分类系统。本综述旨在总结癌症免疫治疗后TAN亚群中观察到的变化,并确定促肿瘤亚群和抗肿瘤亚群之间的差异和共性。还强调了临床前和临床研究的当前进展,包括针对TANs的新型疗法。